The CADScor®System is an innovative, ultrasensitive analytical device designed to support a safe, reliable and cost-effective rule-out of significant CAD at the very first stage of the diagnostic pathway. The user-friendly test records and analyses the heart sounds of the patient and can be conducted by all trained healthcare professional.
An easy solution to bring down costs, risk and stress
Non-invasive, point-of-care-test reducing waiting time and stress for patients
User-friendly, accurate and reliable rule-out device to be used prior to other testing
Cost-effective and safe diagnostic aid displaying immediate results
See how the CADScor®System works
Based on acoustic technology, the CADScor®System records the heart sounds of the resting patient to analyse the myocardial movement and blood flow in the coronary arteries. The recording detects heart sound abnormalities, such as coronary murmurs correlated to coronary stenosis and stiffness. In less than ten minutes, the results are shown as a calculated CAD-score from 0-99, categorizing patients into three risk groups.
“The CADScor®System gives you peace of mind in just 10 minutes”
Acarix is a medical technology company marketing the CADScor®System, currently available in Sweden, Denmark and Germany. The CADScor®System is developed from pioneering research on phonocardiography, providing an innovative, non-invasive and ultra-sensitive analytical diagnostic aid for immediate rule-out. The cost-effective and simple test reduces the waiting time and stress for patients experiencing symptoms of CAD. Since 2016, Acarix is listed on Nasdaq First North Growth Market.
Henrik Nilsson our new Sales Director for the Nordic Region and Achim Müller our new Sales Manager, Germany will help us to continuously strengthen our presence and develop our business in the Nordic area as well as in the DACH region.
Emerging Medtech Summit, CA, US
The Ritz-Carlton Laguna Niguel - Dana Point, CA - February 18-20th, 2020
Partner on the Pacific with the investors, innovators, and strategics building the future of medtech.
Per Persson, CEO Acarix presents 2nd day at...